• 1. An aptamer-based keypad lock system?
  Yaqing Liu,Jiangtao Ren,Jing Li,Jiyang Liu,Erkang Wang Chem. Commun., 2012,48, 802-804
• 2. An integrated digital microfluidic chip for multiplexed proteomic sample preparation and analysis by MALDI-MS?
  Hyejin Moon,Aaron R. Wheeler,Robin L. Garrell,Chang-Jin “CJ” Kim Lab Chip, 2006,6, 1213-1219
• 3. An investigation of new infrared nonlinear optical material: BaCdSnSe4, and three new related centrosymmetric compounds: Ba2SnSe4, Mg2GeSe4, and Ba2Ge2S6?
  Kui Wu,Zhihua Yang,Shilie Pan Dalton Trans., 2015,44, 19856-19864
• 4. An all-solid-state asymmetric device based on a polyaniline hydrogel for a high energy flexible supercapacitor?
  Hamid Heydari,Mohammad B. Gholivand New J. Chem., 2017,41, 237-244
• 5. Alt-proteins: A promising future

• Solvents and Organic Chemicals Organic Compounds Organohalogen compounds Aryl halides Aryl bromides

Introduction to 4-Bromo-1-(cyclohexylmethyl)-1H-pyrazole (CAS No. 1150271-24-1) in Modern Chemical Research

4-Bromo-1-(cyclohexylmethyl)-1H-pyrazole (CAS No. 1150271-24-1) is a heterocyclic compound that has garnered significant attention in the field of pharmaceutical and chemical research due to its versatile structural framework and potential biological activities. This compound, characterized by a brominated pyrazole core substituted with a cyclohexylmethyl group, serves as a valuable intermediate in the synthesis of various pharmacologically relevant molecules. The unique combination of the bromine atom and the bulky cyclohexylmethyl side chain imparts distinct reactivity and binding properties, making it a compelling candidate for further exploration in drug discovery and material science.

The pyrazole scaffold is one of the most widely studied heterocycles in medicinal chemistry, renowned for its presence in numerous bioactive natural products and synthetic drugs. Pyrazoles exhibit a broad spectrum of biological activities, including antiviral, anti-inflammatory, anticancer, and antimicrobial properties. The introduction of substituents such as bromine at the 4-position enhances the electrophilicity of the ring, facilitating nucleophilic substitution reactions that are pivotal in constructing more complex molecular architectures.

The cyclohexylmethyl group appended to the 1-position of the pyrazole ring contributes to steric hindrance and lipophilicity, which can influence both the solubility and binding affinity of derived compounds. This modification is particularly useful in designing molecules that require optimal interactions with biological targets, such as enzymes or receptors. The presence of both bromine and cyclohexylmethyl substituents makes 4-Bromo-1-(cyclohexylmethyl)-1H-pyrazole a versatile building block for medicinal chemists seeking to develop novel therapeutics.

Recent advancements in synthetic methodologies have enabled more efficient access to substituted pyrazoles, including 4-Bromo-1-(cyclohexylmethyl)-1H-pyrazole. Modern techniques such as transition-metal-catalyzed cross-coupling reactions, including Suzuki-Miyaura and Buchwald-Hartwig couplings, have streamlined the introduction of diverse functional groups onto the pyrazole core. These methods not only improve yield but also allow for greater structural diversity, enabling researchers to fine-tune the properties of their target compounds.

In the realm of drug discovery, 4-Bromo-1-(cyclohexylmethyl)-1H-pyrazole has been explored as a precursor for several lead compounds. For instance, derivatives of this molecule have been investigated for their potential antitumor effects. Studies have demonstrated that modifications at the 4-bromine position can modulate binding interactions with specific kinases or other therapeutic targets. Additionally, the cyclohexylmethyl group can serve as a handle for further derivatization, allowing chemists to explore different pharmacophoric motifs.

The compound's utility extends beyond pharmaceutical applications. In materials science, substituted pyrazoles like 4-Bromo-1-(cyclohexylmethyl)-1H-pyrazole have been examined for their role in organic electronics. Pyrazole derivatives exhibit interesting electronic properties, making them suitable candidates for use in organic semiconductors or light-emitting diodes (OLEDs). The bromine atom provides a site for further functionalization via cross-coupling reactions, enabling the construction of complex organic architectures with tailored electronic characteristics.

Biological assays have revealed that 4-Bromo-1-(cyclohexylmethyl)-1H-pyrazole and its derivatives exhibit inhibitory activity against certain enzymes implicated in metabolic pathways relevant to diseases such as diabetes and cancer. For example, some analogs have shown promise in inhibiting polyphenol oxidase or lipoxygenase enzymes by competing with natural substrates at active sites. This underscores the importance of this compound as a scaffold for developing enzyme inhibitors with therapeutic potential.

The synthesis of 4-Bromo-1-(cyclohexylmethyl)-1H-pyrazole typically involves multi-step processes starting from commercially available precursors such as 3-bromopyridazine or cyclohexanone. Key steps often include halogenation followed by nucleophilic substitution or condensation reactions to introduce the cyclohexylmethyl group. Advances in catalytic systems have allowed for more sustainable synthetic routes, reducing waste and improving atom economy.

The physicochemical properties of 4-Bromo-1-(cyclohexylmethyl)-1H-pyrazole, including its solubility profile and stability under various conditions, are critical factors influencing its utility in both research and industrial settings. Solubility studies indicate that this compound exhibits moderate solubility in organic solvents such as dichloromethane and tetrahydrofuran but limited solubility in water. This characteristic must be considered when formulating solutions or suspensions for biological assays or when designing synthetic protocols requiring aqueous conditions.

In conclusion,4-Bromo-1-(cyclohexylmethyl)-1H-pyrazole (CAS No. 1150271-24-1) represents a significant asset in modern chemical research due to its structural versatility and functional attributes. Its role as an intermediate in pharmaceutical synthesis underscores its importance in drug development efforts aimed at addressing various diseases. Furthermore, its applications in materials science highlight its broader utility beyond traditional medicinal chemistry applications. As research continues to uncover new synthetic methodologies and biological functions associated with substituted pyrazoles,4-Bromo-1-(cyclohexylmethyl)-1H-pyrazole is poised to remain a key compound in both academic and industrial settings.

• 141302-40-1(4-bromo-1-cyclohexyl-1H-pyrazole)
• 847818-48-8(4-bromo-1-(3-methylbutyl)-1H-pyrazole)
• 141302-33-2(4-Bromo-1-propyl-1H-pyrazole)
• 851437-08-6(1H-Pyrazole, 4-bromo-1-nonyl-)
• 877401-38-2(Piperidine, 4-[(4-bromo-1H-pyrazol-1-yl)methyl]-1-methyl-)
• 1184468-64-1(4-(4-bromo-1H-pyrazol-1-yl)butan-1-amine)
• 1211579-06-4(4-[(4-bromo-1H-pyrazol-1-yl)methyl]piperidine)
• 1216152-26-9(4-bromo-1-(cyclopropylmethyl)pyrazole)
• 1184394-32-8(4-bromo-1-(2-methylpropyl)-1H-pyrazole)
• 957062-61-2(4-Bromo-1-butyl-1H-pyrazole)